TrademarkDir
OPSIS THERAPEUTICS
DEAD

Serial Number

87182705

Owner

Opsis Therapeutics, LLC

Attorney

Jason M. Hunt

Filing Date

Sep 26, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OPSIS THERAPEUTICS Trademark

Serial Number: 87182705

OPSIS THERAPEUTICS is a trademark filed by Opsis Therapeutics, LLC on September 26, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Opsis Therapeutics, LLC (2 trademarks)

525 Science Drive
Madison, WI 53711

Entity Type: 16

Trademark Details

Filing Date

September 26, 2016

Registration Date

Not Registered

Published for Opposition

May 2, 2017

Goods & Services

Cell based preparations derived from human stem cells for treatment of ocular disorders; cell based products derived from human stem cells useful for treatment of ocular disorders, namely, living tissue grafts for surgical implantation

Cell based products derived from human stem cells useful for treatment of ocular disorders, namely, non-living tissue grafts for surgical implantation

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 3, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 3, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2019 EXRA
SOU EXTENSION 5 GRANTED
Dec 2, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 2, 2019 AITU
SOU EXTENSION 5 FILED
Nov 22, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 22, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 22, 2019 EXRA
SOU EXTENSION 4 GRANTED
May 20, 2019 EX4G
SOU EXTENSION 4 FILED
May 20, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
May 20, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2018 EXRA
SOU EXTENSION 3 GRANTED
Dec 27, 2018 EX3G
SOU EXTENSION 3 FILED
Dec 27, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 27, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 16, 2018 EXRA
SOU EXTENSION 2 GRANTED
Jun 14, 2018 EX2G
SOU EXTENSION 2 FILED
Jun 14, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 14, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2017 EXRA
SOU EXTENSION 1 GRANTED
Dec 12, 2017 EX1G
SOU EXTENSION 1 FILED
Dec 12, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 12, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 27, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 2, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 2, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 12, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 24, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2017 TROA
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Jan 6, 2017 CEPE
ASSIGNED TO LIE
Jan 5, 2017 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 5, 2017 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 5, 2017 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jan 5, 2017 CPEA
ASSIGNED TO EXAMINER
Jan 3, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2016 NWOS
NEW APPLICATION ENTERED
Sep 29, 2016 NWAP

Related Trademarks

More from this Owner

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS

OPSIS THERAPEUTICS